A close-up photo of a person holding the TWYNEO cream bottle close to their face.

What to expect

Not an actual patient.

Proven to rapidly clear skin

Some people saw results in just 2 weeks, and their skin continued to clear over time.1,2*

PATIENT:
1
2
3
A series of photos showing patient progress using TWYNEO cream at Week 0, 2, 4, 8, and 12.
A series of photos showing patient progress using TWYNEO cream at Week 0, 2, 4, 8, and 12.
A series of photos showing patient progress using TWYNEO cream at Week 0, 2, 4, 8, and 12.
A series of photos showing patient progress using TWYNEO cream at Week 0, 2, 4, 8, and 12.
A series of photos showing patient progress using TWYNEO cream at Week 0, 2, 4, 8, and 12.
A series of photos showing patient progress using TWYNEO cream at Week 0, 2, 4, 8, and 12.
A series of photos showing patient progress using TWYNEO cream at Week 0, 2, 4, 8, and 12.
A series of photos showing patient progress using TWYNEO cream at Week 0, 2, 4, 8, and 12.
A series of photos showing patient progress using TWYNEO cream at Week 0, 2, 4, 8, and 12.

Male

Female

Male

Study SGT-65-04: double-blind, randomized, vehicle-controlled safety and efficacy 12-week study of tretinoin cream, 0.1% and benzoyl peroxide cream, 3% vs vehicle cream.1

Tested by teens: assessed in 2 clinical studies that evaluated 858 people ages 9 or older with facial acne vulgaris, including 370 people ages 12-17 years, for 12 weeks.

Practice some selfie care

Show off your own before and after selfies using #TWYNEO

An illustration of a smiley face next to a smart phone.
An illustration of 10 people in different poses. 9 of them are in happy poses and 1 of them is in an angry pose.
Greater than 90%

of people who used TWYNEO cream in clinical studies said they liked what they saw in the mirror at Week 121,2

A photo of a hand with a pea-sized amount of TWYNEO cream on the index finger.

Designed with your skin in mind

TWYNEO cream was proven to have fewer side effects, so you can use it every day, just as your doctor prescribes.

*

Noninflammatory lesion reduction at Week 2.1,2

References: 1. Galderma Laboratories, L.P.; data on file. Clinical Study Report SGT-65-04; May 28, 2020. 2. Galderma Laboratories, L.P.; data on file. Clinical Study Report SGT-65-05; June 5, 2020.